Publication date: Nov 08, 2019
For the first time, a guideline recommends that screening for colorectal cancer should not be routinely carried out for all adults aged 50 to 79 years, but instead be limited to individuals with an elevated level of risk. An accompanying editorial suggests that the new guideline on colorectal cancer screening represents a -radical shift that prioritizes informed choice over maximizing uptake. ” A cursory glance at other guideline recommendations on prostate and breast cancer screening also shows just how confusing it can get. On prostate cancer screening, it’s been more than two years since a prominent panel of U. S. healthcare experts reversed an earlier position it took against the prostate-specific antigen, or PSA, blood test. And, new recommendations disseminated last year confirmed the value of annual mammographic screening for women in their 40s. To illustrate, periodically, the American Cancer Society publishes a summary of guidelines for early cancer detection, data and trends in cancer screening rates, and prominent issues related to cancer screening. In the case of cancer screening, the questions individuals want answers to include: When should screening begin? Individuals should be informed about the benefits and risks of different kinds of cancer screening and make decisions that best reflect their personal values and preferences.
- Implementation best practices: The optimal way to approach security
- Exercise Will Be Soon Prescribed Like Medicine For Cancer Patients
- Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions.
- Understanding Precision Medicine And AI Within The Life Cycle Of Technology Revolutions